当前位置：
X-MOL 学术
›
Sci. Bull.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial
Science Bulletin ( IF 18.8 ) Pub Date : 2023-12-26 , DOI: 10.1016/j.scib.2023.12.046 Si-Yang Maggie Liu 1 , Jie Huang 2 , Jia-Yi Deng 2 , Chong-Rui Xu 2 , Hong-Hong Yan 3 , Ming-Yi Yang 2 , Yang-Si Li 2 , E-E Ke 2 , Ming-Ying Zheng 2 , Zhen Wang 2 , Jia-Xin Lin 2 , Bin Gan 2 , Xu-Chao Zhang 2 , Hua-Jun Chen 2 , Bin-Chao Wang 2 , Hai-Yan Tu 2 , Jin-Ji Yang 2 , Wen-Zhao Zhong 2 , Yangqiu Li 4 , Qing Zhou 3 , Yi-Long Wu 3
Science Bulletin ( IF 18.8 ) Pub Date : 2023-12-26 , DOI: 10.1016/j.scib.2023.12.046 Si-Yang Maggie Liu 1 , Jie Huang 2 , Jia-Yi Deng 2 , Chong-Rui Xu 2 , Hong-Hong Yan 3 , Ming-Yi Yang 2 , Yang-Si Li 2 , E-E Ke 2 , Ming-Ying Zheng 2 , Zhen Wang 2 , Jia-Xin Lin 2 , Bin Gan 2 , Xu-Chao Zhang 2 , Hua-Jun Chen 2 , Bin-Chao Wang 2 , Hai-Yan Tu 2 , Jin-Ji Yang 2 , Wen-Zhao Zhong 2 , Yangqiu Li 4 , Qing Zhou 3 , Yi-Long Wu 3
Affiliation
|
[Display omitted]
中文翻译：
在未经治疗的晚期非小细胞肺癌患者中，信迪利单抗与派姆单抗联合或不联合铂类双药化疗的 PD-L1 表达指导 (CTONG1901)：一项 2 期随机对照试验
[显示省略]
更新日期：2023-12-26
中文翻译：
在未经治疗的晚期非小细胞肺癌患者中，信迪利单抗与派姆单抗联合或不联合铂类双药化疗的 PD-L1 表达指导 (CTONG1901)：一项 2 期随机对照试验
[显示省略]
京公网安备 11010802027423号